TrialInternational journal of radiation oncology, biology, physics2016

Eastern Cooperative Oncology Group and American College of Radiology Imaging Network Randomized Phase 2 Trial of Neoadjuvant Preoperative Paclitaxel/Cisplatin/Radiation Therapy (RT) or Irinotecan/Cisplatin/RT in Esophageal Adenocarcinoma: Long-Term Outcome and Implications for Trial Design.

Lawrence R Kleinberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.